Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Landos Biopharma, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 8 | 11 | +3 |
| Shares | 1.49M | 1.53M | +37.8K (+2.5%) |
| Value | $6.27M | $5.93M | −$340.4K (−5.4%) |
New holders (3)
Institutions that held Landos Biopharma, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Macquarie Group Ltd | 14,718 | $57.0K | 0.00% |
| Geode Capital Management, LLC | 12,604 | $48.8K | 0.00% |
| Renaissance Technologies LLC | 10,260 | $40.0K | 0.00% |
Sold out (0)
Institutions that held Landos Biopharma, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
None.